Heart Disease Risk Factors

Qureshi, N., Woods, B., de Faria, N., Goncalves, S., Cox, E., Bee, L., et al. (2023). Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health Technol Assess, 27, 1-140. http://doi.org/10.3310/ctmd0148
Yu, D., Huang, X., Mamas, M. A., & Wilkie, R. (2023). Persistent high prevalence of modifiable cardiovascular risk factors among patients with osteoarthritis in the UK in 1992-2017. Rmd Open, 9. http://doi.org/10.1136/rmdopen-2023-003298
Livingstone, S., Morales, D. R., Fleuriot, J., Donnan, P. T., & Guthrie, B. (2023). External validation of the QLifetime cardiovascular risk prediction tool: population cohort study. Bmc Cardiovasc Disord, 23, 194. http://doi.org/10.1186/s12872-023-03209-8
Conrad, N., Verbeke, G., Molenberghs, G., Goetschalckx, L., Callender, T., Cambridge, G., et al. (2022). Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet, 400, 733-743. http://doi.org/10.1016/s0140-6736(22)01349-6
Dziopa, K., Asselbergs, F. W., Gratton, J., Chaturvedi, N., & Schmidt, A. F. (2022). Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings. Diabetologia, 65, 644-656. http://doi.org/10.1007/s00125-021-05640-y